You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

NHL

Showing 1 - 25 of 1,420
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NHL, NHL, Relapsed, Adult Trial in United States (CLN-978)

Recruiting
  • NHL
  • NHL, Relapsed, Adult
  • Birmingham, Alabama
  • +4 more
May 31, 2023

B-cell NHL, CLL Trial (CARCIK-CD19)

Not yet recruiting
  • B-cell NHL
  • CLL
  • CARCIK-CD19
  • (no location specified)
May 19, 2023

Diffuse Large B Cell Lymphoma Trial in Shanghai (BTK inhibitor, PD-1 inhibitor)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • BTK inhibitor
  • PD-1 inhibitor
  • Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
May 20, 2023

(CHANT)Real World Study of Duvelisib in Treatment of

Not yet recruiting
  • Follicular Lymphoma
  • +5 more
  • (no location specified)
Jun 20, 2023

NHL, Adult, AML, Adult Recurrent Trial in Zhengzhou, Tianjin (ETH-155008)

Recruiting
  • NHL, Adult
  • AML, Adult Recurrent
  • Zhengzhou, Henan, China
  • +1 more
Feb 24, 2023

Hodgkin Lymphoma, B-Cell Lymphoma, Relapsed B-cell NHL Trial in Houston (Mosunetuzumab, Polatuzumab vedotin, Tafasitamab)

Not yet recruiting
  • Hodgkin Lymphoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 7, 2022

B-cell Non Hodgkin Lymphoma Trial in Xuzhou (regimen with BTK inhibitor +Anti-CD19 CAR T cells)

Recruiting
  • B-cell Non Hodgkin Lymphoma
  • regimen with BTK inhibitor +Anti-CD19 CAR T cells
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Feb 23, 2023

Auto/Allo Tandem Transplant for Relapsed B-NHL

Completed
  • Non Hodgkin Lymphoma
  • auto transplant followed by allo transplant
  • (no location specified)
Oct 24, 2022

SALVAGE TREATMENT WITH GLOFITAMAB IN RELAPSED/REFRACTORY B-NHL:

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • +2 more
    • (no location specified)
    Jun 22, 2023

    CD20-positive Non-Hodgkin Lymphoma Trial in Seoul (Rituximab + MG4101)

    Terminated
    • CD20-positive Non-Hodgkin Lymphoma
    • Rituximab + MG4101
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Oct 24, 2022

    NHL, Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis, Saint Louis (FT596, Rituximab)

    Suspended
    • NHL
    • +3 more
    • Minneapolis, Minnesota
    • +1 more
    Jan 31, 2023

    B-cell Non-Hodgkin Lymphoma (B-NHL) Trial in Austin (UCART20x22, CLLS52)

    Recruiting
    • B-cell Non-Hodgkin Lymphoma (B-NHL)
    • UCART20x22
    • CLLS52
    • Austin, Texas
      Sarah Cannon - St. David South Austin Medical Center
    Dec 8, 2022

    Relapsed or Refractory Mantle Cell Lymphoma (MCL) Trial in Duarte (BAFFR-CAR T cells)

    Recruiting
    • Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
    • BAFFR-CAR T cells
    • Duarte, California
      City of Hope Medical Center
    Oct 18, 2022

    NK/T Cell Lymphoma, Vascular Immunomother T Cell Lymphoma, Non-Hodgkin Lymphoma Trial in Guangzhou (GNC-038)

    Not yet recruiting
    • NK/T Cell Lymphoma
    • +2 more
    • Guangzhou, Guangdong, China
    • +1 more
    Jan 12, 2023

    LY007 for r/r B-NHL and Exploration of Novel CAR-T Translational

    Not yet recruiting
    • Relapsed Non-Hodgkin Lymphoma
      • (no location specified)
      Sep 19, 2023

      Lymphoma, Non-Hodgkin, Lymphoma, T-Cell Trial in Najing (Recombinant Humanized Anti-CD52 Monoclonal Antibody Injection)

      Recruiting
      • Lymphoma, Non-Hodgkin
      • Lymphoma, T-Cell
      • Recombinant Humanized Anti-CD52 Monoclonal Antibody Injection
      • Najing, Jiangsu, China
        Jiangsu Provincial People's Hospital
      Sep 26, 2022

      Non-Hodgkin's Lymphoma Trial (MBS303)

      Not yet recruiting
      • Non-Hodgkin's Lymphoma
      • (no location specified)
      Apr 6, 2023

      Lymphoma, Large B-Cell, Diffuse, Follicular Lymphoma Grade 3B, High-grade B-cell Lymphoma Trial in China (Relmacabtagene

      Not yet recruiting
      • Lymphoma, Large B-Cell, Diffuse
      • +3 more
      • Relmacabtagene Autoleucel
      • +2 more
      • Guangzhou, Guangdong, China
      • +12 more
      Oct 24, 2023

      Advanced Malignancies Trial in Beijing (1A46 Drug Substance)

      Not yet recruiting
      • Advanced Malignancies
      • 1A46 Drug Substance
      • Beijing, Beijing, China
        Beijing Cancer Hospital
      Aug 4, 2023

      B Cell NHL, CLL Trial in Sydney, Melbourne, Mount Pleasant (GB261)

      Recruiting
      • B Cell NHL
      • CLL
      • GB261
      • Sydney, New South Wales, Australia
      • +4 more
      Nov 16, 2022

      NHL, Leukemia Trial in Australia (ETH-155008)

      Recruiting
      • NHL
      • Leukemia
      • Adelaide, South Australia, Australia
      • +4 more
      Jun 8, 2022

      Solid Tumors, NHL Trial in Canada, United States (KPT-9274, Niacin ER, Nivolumab)

      Terminated
      • Solid Tumors
      • NHL
      • Los Angeles, California
      • +7 more
      Jan 18, 2023

      NHL Trial in Santa Monica (IGN002)

      Withdrawn
      • NHL
      • IGN002
      • Santa Monica, California
        UCLA
      Feb 23, 2022

      B-cell Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma Trial in Aurora (CD19CAR-CD3Zeta-4-1BB-Expressing Autologous

      Recruiting
      • B-cell Acute Lymphoblastic Leukemia
      • B-cell Non Hodgkin Lymphoma
      • CD19CAR-CD3Zeta-4-1BB-Expressing Autologous T-Lymphocyte Cells
      • Aurora, Colorado
        Children's Hospital Colorado
      Nov 9, 2022

      Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell Trial (ONO-7018)

      Not yet recruiting
      • Lymphoma, Non-Hodgkin
      • Leukemia, Lymphocytic, Chronic, B-Cell
      • (no location specified)
      Aug 23, 2022